2023-02-24
Notice of Completion of Series A Funding of Approximately 560 Million Yen
CTBE has completed Series A Funding in January 2023. A total of approximately 560 million yen in series A funding was raised through the following investors.
Waseda Innovation Fund No. 3 Investment Partnership
Teijin Limited
Japan Science and Technology Agency
AXA Life Insurance Co., Ltd.
NextG Investment Business Limited Liability Partnership
Sun Global Co., Ltd.
With this funding, CTBE will accelerate the commercialization of artificial ligaments for anterior cruciate ligament reconstruction surgery.
2024-10-15
CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation
2023-11-15
Kiyotaka Iwasaki will be on stage as a speaker at the 1st Japanese Knee Society Conference, held on December 8th, 2023
2023-10-12
CTBE will attend JHVS 2023 in Yokohama